Servier is an independant pharmaceutical company commited to therapeutic progress to serve patient needs. Its unique governance allows Servier to reinvest all its profits to support its development, as well as plan and invest with a long-term view, in line with its vocation.
Some insights
Primary therapeutic areas: Cancer / neurological diseases / autoimmune diseases / cardiovascular diseasesTherapeutic modalities: Small molecules, RNA therapies, Antibody